The process of preparing AOD-9604 for administration involves reconstitution. This refers to dissolving the lyophilized, or freeze-dried, peptide in a sterile liquid. For example, bacteriostatic water is often used as the solvent to create a stable and injectable solution.
Proper reconstitution is crucial for maintaining the integrity and efficacy of AOD-9604. A correctly prepared solution ensures accurate dosing and maximizes the potential benefits. Historical context surrounding peptide therapies underscores the importance of precise handling to avoid degradation and ensure consistent results.
